MA H1364

Requires health insurers and pharmacy benefit managers to pass at least 80% of estimated prescription drug rebates directly to patients at the point of sale, reducing out-of-pocket costs

Repeals Sections 131 and 226 of Chapter 139 of the Acts of 2012

Mandates annual compliance reports from carriers to the Division of Insurance by April 1, with fines up to $5,000 per day for noncompliance

Protects rebate information as confidential trade secrets, prohibiting pharmacy benefit managers from publicly disclosing product-specific or manufacturer-specific rebate amounts

Directs the Health Policy Commission and Executive Office of Health and Human Services to study cell and gene therapy access barriers for MassHealth patients, with a report due by July 30, 2028, covering the forecast period of 2027-2037